Based on last quarters cash flow, my guess is they will have about 2.8-2.9mil at the end of September. So if they see the alteration zones as potential vectors to the primary ore and the DHEM comes up good then maybe they just have to back themselves and go for it without a raising.
This is clearly a riskier approach but has high reward for existing shareholders. Or do they take the conservative approach, as raising conditions have improved a bit compared to 3 or 4 months ago and take advantage of this. I would personally like to see a small placement to Antofagasta at a much a higher price, this would be an outward sign that they are interested in Enigma which would give confidence to the market and secondly it may give a bit of stability to the share price, it could even act as a floor.
Unfortunately the royalties from Ashburton are a very long way from fruition. Would the rights to Woodline be worth anything?
All my opinion
GV
- Forums
- ASX - By Stock
- SRI
- yesterdays announcement
yesterdays announcement, page-17
Featured News
Add SRI (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.966M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 143919 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 10888 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 143919 | 0.013 |
4 | 413240 | 0.012 |
1 | 318000 | 0.011 |
3 | 469883 | 0.010 |
2 | 182500 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 10888 | 1 |
0.015 | 251000 | 1 |
0.019 | 72259 | 1 |
0.020 | 75063 | 2 |
0.021 | 193311 | 2 |
Last trade - 11.36am 15/11/2024 (20 minute delay) ? |
Featured News
SRI (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online